Ad
related to: astrazeneca covid-19 vaccine
Search results
AstraZeneca CEO Has No Plans to Retire as He Seeks to Nearly Double Sales by 2030
The Wall Street Journal· 1 day agoAstraZeneca’s longest-serving chief executive, Pascal Soriot, has no plans to step down for now as...
Lessons for the 'next pandemic': UNMC's Khan named to national CDC vaccine study committee
Omaha World-Herald· 13 hours agoThe dean of the University of Nebraska Medical Center’s College of Public Health is among more than...
Scientists Decode Deadly Blood Clot Disorder Triggered by COVID Vaccines
SciTechDaily· 6 days agoNew research has shown that the dangerous PF4 antibodies involved in vaccine-induced thrombosis...
COVID Shot After Acute Coronary Syndrome Might Not Prevent Further Events
MedPage Today· 2 days agoCensoring the first 90 days post-vaccination in this non-randomized comparison, people with ACS who...
Germany lifts mandatory COVID vaccination requirement for military following committee...
Fox News· 3 days agoGermany has removed the mandate for its military service members to be vaccinated against COVID-19,...
Novavax’s R&D head, integral to Covid vaccine work, to retire - Washington Business Journal
The Business Journals· 3 days agoThe head of research and development at Novavax Inc., a key player in the development of its Covid-...
Chikungunya Vaccine Backed by European Medicines Agency
Medscape· 2 days agoIxchiq is the first vaccine for protection against chikungunya to be recommended for European Union...
Pfizer (PFE) Up 1.8% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 1 day agoPerformance of an Industry Player Pfizer belongs to the Zacks Large Cap Pharmaceuticals industry....
The Global Blood Supply May Be Massively Contaminated
Mercola· 6 days agoIn a recent meta-analysis1,2 posted on preprints.org, Japanese researchers warn of potentially deadly risks to patients who receive blood from people who have taken mRNA COVID
Feds plan for smoother access to RSV infant shot
Politico· 3 days agoThe FDA issued a priority review voucher to Pfizer for its Covid-19 antiviral Paxlovid. The company can use the voucher to expedite the review of a future ...